Document is current
Any future updates will be listed below
-
Authors
Seidlberger, S.
Schirmer, M.
Wietzorrek, G.
Jiménez-Heffernan, J. A.
Pardines, M.
de las Fuentes Monreal, M.
González-Gay, M. A.
Castañeda, S.
Santos-Sierra, S.
-
Funding
Funding for this research was provided by:
Austrian Science Fund (P35219-B)
ISCiii (INVESTIGO 2022-C23.I01.P03.S0020-0000031, RICORS (RD24/0007/0031), PI21/0147)
- License Information
-
More Information
Article History
Received: 23 April 2025
Accepted: 7 October 2025
First Online: 12 November 2025
Declarations
:
: The study was performed in accordance with the recommendations of the institutional ethic commission of the University Hospital La Princesa, Madrid, Spain (internal code number 5102/2023) and the Medical University of Innsbruck (AN3950 287/4.5 431/AM2 (4555a)). All subjects gave a written informed consent prior to their inclusion in the study.
: Not applicable.
: Authors S. Seidlberger, G. Wietzorrek G, JA. Jiménez-Heffernan, M. Pardines, M. de las Fuentes Monreal and S. Santos-Sierra declare they have no financial interests. Author M. Schirmer received educational grants from AbbVie Austria. M. A. Gonzalez-Gay has had consultation fees/participation in company sponsored speaker´s bureau from GSK, Otsuka, Sanofi, Amgen and Novo-Nordisk. S. Castañeda received consultation fees and participated in the company sponsored speaker’s bureau from Amgen, Grünenthal Pharma, Eli-Lilly, Gedeon-Richter, Janssen, Roche, and UCB Spain. None of the financial disclosures has any relation to this work.
